南非心脏协会关于卵圆孔未闭封堵术的 2021 共识声明
SA Heart consensus statement on closure of patent foramen ovale 2021.
机构信息
Medical School, University of Cape Town, Cape Town, South Africa.
Netcare, Kuils River Hospital, Cape Town, South Africa.
出版信息
Cardiovasc J Afr. 2023;34(1):35-39. doi: 10.5830/CVJA-2022-009. Epub 2022 Jun 8.
Abstract
A patent foramen ovale (PFO) is associated with numerous clinical conditions. The most severe of these is cryptogenic stroke. This consensus statement aims to provide a clinical guideline on which patients should be offered PFO closure.
摘要
卵圆孔未闭（PFO）与许多临床病症相关联。其中最严重的是隐源性卒中。本共识声明旨在提供临床指南，指导哪些患者应接受 PFO 封堵。
相似文献
1
SA Heart consensus statement on closure of patent foramen ovale 2021.
Cardiovasc J Afr. 2023;34(1):35-39. doi: 10.5830/CVJA-2022-009. Epub 2022 Jun 8.
2
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.
3
Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
Cerebrovasc Dis. 2018;45(3-4):162-169. doi: 10.1159/000487959. Epub 2018 Mar 29.
4
Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
Catheter Cardiovasc Interv. 2018 Jul;92(1):165-173. doi: 10.1002/ccd.27615. Epub 2018 Mar 30.
5
Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
Catheter Cardiovasc Interv. 2018 Jul;92(1):176-186. doi: 10.1002/ccd.27636. Epub 2018 May 4.
6
Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.115.003470.
7
The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Circ Cardiovasc Interv. 2018 Mar;11(3):e004152. doi: 10.1161/CIRCINTERVENTIONS.117.004152.
8
Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
JACC Cardiovasc Interv. 2013 Dec;6(12):1316-23. doi: 10.1016/j.jcin.2013.08.001. Epub 2013 Oct 16.
9
Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.
Stroke. 2020 Oct;51(10):3119-3123. doi: 10.1161/STROKEAHA.120.029350. Epub 2020 Sep 14.
10
Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Stroke - An Updated Comprehensive Meta-Analysis.
Cardiovasc Revasc Med. 2019 Aug;20(8):687-694. doi: 10.1016/j.carrev.2018.09.010. Epub 2018 Sep 19.
本文引用的文献
1
Cardiovascular MRI Compared to Echocardiography to Identify Cardioaortic Sources of Ischemic Stroke: A Systematic Review and Meta-Analysis.
Front Neurol. 2021 Jul 30;12:699838. doi: 10.3389/fneur.2021.699838. eCollection 2021.
2
Large eustachian valve fostering paradoxical thromboembolism: passive bystander or serial partner in crime?
World J Cardiol. 2021 Jul 26;13(7):204-210. doi: 10.4330/wjc.v13.i7.204.
3
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions.
Eur Heart J. 2021 Apr 21;42(16):1545-1553. doi: 10.1093/eurheartj/ehaa1070.
4
Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.
Stroke. 2020 Oct;51(10):3119-3123. doi: 10.1161/STROKEAHA.120.029350. Epub 2020 Sep 14.
5
Transcranial Doppler as a Screening Tool for High-Risk Patent Foramen Ovale in Cryptogenic Stroke.
J Neuroimaging. 2021 Jan;31(1):165-170. doi: 10.1111/jon.12783. Epub 2020 Sep 8.
6
Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study.
Ann Intern Med. 2020 Jun 2;172(11):717-725. doi: 10.7326/M19-3583. Epub 2020 May 12.
7
Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review.
Front Neurol. 2020 Apr 28;11:281. doi: 10.3389/fneur.2020.00281. eCollection 2020.
8
Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke: Development of a Scoring System.
J Am Soc Echocardiogr. 2019 Jul;32(7):811-816. doi: 10.1016/j.echo.2019.03.021. Epub 2019 May 23.
9
A comparison of contrast transthoracic echocardiography and contrast transcranial Doppler in cryptogenic stroke patients with patent foramen ovale.
Brain Behav. 2019 May;9(5):e01283. doi: 10.1002/brb3.1283. Epub 2019 Apr 2.
10
Updated meta-analysis of closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
Cardiovasc Revasc Med. 2019 Mar;20(3):187-193. doi: 10.1016/j.carrev.2018.06.001. Epub 2018 Jun 13.
Zotero 插件